Astragalus Root Extraction: The Source of TA-65
Astragalus Root Extraction: The Source of TA-65
TA-65 is derived from the root of Astragalus membranaceus, a plant whose saponin molecules, including cycloastragenol and astragaloside IV, are studied in telomere biology research. This educational guide from RevGenetics explains the source plant, the studied molecules, and how a concentrated, standardized extract is produced from the raw root.
The Source Plant: Astragalus membranaceus
TA-65 begins with a single botanical source: the root of Astragalus membranaceus, a flowering plant in the legume family. The plant has a long history of use in traditional herbal systems, where the dried root has been valued for generations. In modern laboratories, attention has shifted to the specific molecules the root contains and how they can be isolated, concentrated, and standardized for consistent quality.
Astragalus root is a complex natural material. It contains polysaccharides, flavonoids, and a class of molecules called saponins. Within that saponin fraction sit the compounds that have drawn the most interest in telomere biology research. Converting a raw agricultural root into a precise, standardized extract is a careful, multi-step process, and it is the foundation of what makes TA-65 a defined product rather than simply ground-up root powder.
Cycloastragenol and Astragaloside IV: The Studied Molecules
Two molecules from Astragalus are most frequently discussed in the context of telomerase research: cycloastragenol and astragaloside IV. Both are triterpenoid saponins. Astragaloside IV is one of the more abundant saponins in the root, while cycloastragenol is a related aglycone molecule that has been studied for its interaction with telomerase. In research settings, these compounds have been examined for their effects on telomerase activity in cells.
It is worth being precise here. The fact that a purified molecule can influence telomerase activity in a laboratory model is a scientific observation about cell biology. RevGenetics describes these molecules for educational purposes and does not claim that they treat, prevent, or cure any condition. TA-65 is a standardized Astragalus-derived preparation associated with this body of research.
From Root to Standardized Extract: The Extraction Process
Turning Astragalus root into a concentrated, standardized extract follows the general principles of botanical extraction. First, the root is harvested, cleaned, and dried to a stable form suitable for processing. The dried material is then milled and subjected to solvent extraction, a step that pulls the desired saponin molecules out of the plant matrix and into a liquid phase. Because the target molecules are present at low natural concentrations, this extraction is designed to capture and enrich them efficiently.
The crude extract that results is far from a finished ingredient. It is purified through a sequence of steps that may include filtration, concentration, and chromatographic separation, techniques that progressively remove unwanted plant material and isolate the molecules of interest. The purified material is then standardized so that each batch contains a defined, consistent amount of the target compounds, and it is tested for quality. The specific commercial method used to produce a given branded extract is proprietary, so this description is general rather than a recipe.
Why Standardization and Purity Matter
The reason all of this process matters is consistency. A natural root varies from harvest to harvest, but a supplement is expected to deliver the same defined amount of its key molecules in every capsule. Standardization is what bridges that gap. By specifying and verifying the concentration of the target compounds, a manufacturer can offer a product whose composition is predictable, which is essential both for quality and for any research that uses the material.
RevGenetics, founded in 2007, emphasizes pharmaceutical-grade purity and third-party lab testing across its longevity line. The featured TA-65 (25 mg) is an Astragalus-derived telomerase activator standardized to 25 mg. To understand the science behind why these molecules are studied, read our companion guides on what telomerase is and on telomere lengthening science, and see our summary of the published TA-65 clinical research.
Frequently Asked Questions
What is Astragalus membranaceus?
Astragalus membranaceus is a flowering plant in the legume family whose root has a long history of use in traditional herbal practice. In modern research the root has been studied as a source of saponin molecules, including the compounds cycloastragenol and astragaloside IV, which are of interest in telomere biology research.
What are cycloastragenol and astragaloside IV?
Cycloastragenol and astragaloside IV are saponin molecules found in or derived from Astragalus membranaceus. They are among the active molecules studied in connection with telomerase activity. TA-65 is a standardized Astragalus-derived preparation associated with this area of research.
How is TA-65 extracted from the root?
In general terms, producing a concentrated Astragalus extract involves harvesting and drying the root, extracting it with solvents, and then purifying and concentrating the target molecules through filtration and chromatography steps, followed by standardization and quality testing. The specific commercial process is proprietary.
Where can I learn more about the finished supplement?
You can see the standardized finished product on the TA-65 (25 mg) page, which provides a 25 mg Astragalus-derived telomerase activator.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
